Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 22Neoplasms 20Leukemia, Myeloid, Acute 10Ovarian Neoplasms 8Neoplasm Metastasis 7Lymphoma 7Lung Neoplasms 7Hematologic Neoplasms 6Glioblastoma 6Colorectal Neoplasms 6Prostatic Neoplasms 5Pancreatic Neoplasms 5Multiple Myeloma 5Leukemia 5Fatigue 5Stomach Neoplasms 4Depression 4Carcinoma, Non-Small-Cell Lung 4Vulvar Neoplasms 3Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pain 3Myelodysplastic Syndromes 3Motor Activity 3Melanoma 3Fallopian Tube Neoplasms 3Carcinoma, Hepatocellular 3

Interventions

Methods 2Eye Movement Desensitization Reprocessing 2Early Intervention, Educational 2Waiting Lists 1Therapeutics 1Registries 1Psilocybin 1Propofol 1Palliative Care 1Meditation 1Medical Marijuana 1Holistic Health 1Exercise Test 1Electroencephalography 1Educational Status 1Coping Skills 1Amyloid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stress Disorders, Post-Traumatic × Palliative Care × Clear all
NCT03652298 2026-03-13

NeuroPrevPTSD

Centre Oscar Lambret

Phase 2 Terminated
19 enrolled
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Neoplasms, Prostatic Neoplasms, Stress Disorders, Post-Traumatic, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡